Universal Ibogaine (TSXV:IBO) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Universal Ibogaine FFO per Share?

FFO per Share only applies to REITs.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue SW, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc. is a Canadian life sciences and healthcare company focused on developing ibogaine-based treatments for addiction and mental health conditions. The company's activities center on two main areas: advancing clinical research into ibogaine, a naturally occurring psychoactive substance derived from the iboga plant, and building a network of addiction treatment clinics, primarily in Canada. Its clinical efforts aim to establish evidence for ibogaine's safety and efficacy in treating substance use disorders, with an initial focus on opioid and other addictions. The company also pursues licensing and clinic operations as a commercial pathway, generating potential revenue through treatment services and related offerings. As an early-stage enterprise, Universal Ibogaine remains largely dependent on financing and partnerships to fund its research programs and clinic rollout, and its operations are concentrated in the Canadian market.